Miso Robotics’ Global Expansion Aims to Provide a 17x Bigger Opportunity for Investors

Top U.S. fast-food brands like Jack in the Box have already adopted Miso’s food-frying and drinking-pouring robots. Now, Miso’s landed a new international partner as the company sets its sights overseas.

SoundExchange Launches Mobile Payment Option For Royalty Distributions

SoundExchange has announced a new initiative that will allow registered creators to receive their royalty payments via mobile payment apps. Cash App is the first mobile payment application in place for registered creators to take advantage of, with additional options available soon.

The initiative builds upon SoundExchange’s release of a mobile app (available for Google and Apple) and digital tools, as well as new partnerships to support creators.

“Meeting creators where they are with easy, accessible tech solutions is a priority for SoundExchange as we enter this next chapter in our journey to support creators,” notes Michael Huppe, President and CEO of SoundExchange. “As mobile payment apps have become increasingly popular, we’ve listened to our community to ensure that we are offering the payment options that best fit their needs. Today’s announcement demonstrates SoundExchange’s leadership in embracing the latest technology trends, and we are happy and excited to have Cash App on board to launch this initiative.”

Creators are encouraged to contact the SoundExchange Customer Services team to learn more about app-specific eligibility requirements and to sign up to receive royalty payments via Cash App.

Creators will still be able to receive royalty payments from SoundExchange via monthly domestic direct deposit in the U.S. and international direct deposit in select local currencies or quarterly paper checks.

The post SoundExchange Launches Mobile Payment Option For Royalty Distributions appeared first on MusicRow.com.

1 Stock to Buy This Week Following Its Recent Earnings Beat

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should…